Chronic Disease Management

The chronic disease management market encompasses consumers with chronic, complex conditions such as chronic kidney disease, diabetes, and heart disease. The challenges faced in this market are often compounded by the need for social services and supports. For provider organizations and health systems managing consumers with chronic conditions, a significant challenge that remains is addressing the rising cost of care for this population. As a result, payers are focusing on reducing the spend by increasing integrated models of care coordination across medical, behavioural, pharmacy, and social support systems. These new market forces are creating strategic opportunities for provider organizations that are serving this population.

Latest Resources

• Large Language Models Show Human-Like Bias Against People With Highly Stigmatized Health Conditions
• Proposed Rule: Medicare & Medicaid Programs; CY 2027 Payment Policies Under The Physician Fee Schedule & Other Changes To Part B Payment & Coverage Policies
• Eisai & CaringKind Launch New Initiative To Address Mealtime & Brain-Healthy Nutrition Needs For People Living With Dementia
• Prisma Health Expands Partnership With Minerra Health & Announces Strategic Investment To Scale Obesity Care Platform
• 4E Therapeutics Acquired By Eli Lilly To Advance Non-Opioid Approach To Chronic Pain
• Obesity Linked To Nearly 15% Of Polypharmacy Cases Among Older Adults
• Evernorth Launches Pharmacy Forward, An AI-Powered Specialty Pharmacy Experience For Those Managing Complex Conditions
• Carrum Health & Virta Health Partner To Deliver Seamless, Full-Spectrum Weight Management Solution For Self-Insured Employers
• True Rx Health Strategists Introduces Healthier You, A Clinical Care Bundle To Help Employers Control Costs & Improve Employee Health
• Sensorum Health Partners With Intermountain Health To Enhance Care Access & Improve Outcomes For Older Adults Across Southern Nevada
• CMS Launches Medicare GLP-1 Bridge Program With $50 Monthly Copayment For Weight Loss Medications
• WeInfuse Announces Partnership With TailorMed To Remove Systematic Medication Barriers For Those Receiving Infusion Treatments
• Lilly Employer Connect Platform Launches With Over 15 Independent Program Administrators Offering Tailored Obesity Coverage Options, Cost Savings 
• CVS Health & Google Cloud Announce New Strategic Partnership For Health100 Subsidiary & AI-Modeled Consumer Engagement Platform
• Thyme Care Launches Integrated Social Support Model, Bringing Proactive Oncology Social Work To Those Diagnosed With Cancer

See All

17% Of Japanese Adults With Chronic Pain Screen Positive For ADHD

Among Japanese adults with chronic pain, 17.1% screened positive for attention-deficit/hyperactivity disorder (ADHD), according to a recent study. The estimated ADHD prevalence among the general population of Japanese adults is 1.65%, compared to 17.1% among those with persistent chronic pain. The highest rate of ADHD-positive screenings, 27.4%, was among those who reported average pain levels of 9 or 10 on a 10-point pain severity scale. The data came from 958 adults who were first-time visitors… Read

• Protocol Behavioral Health Expands Into Illinois Through Partnership With Affiliated Oncologists
• Wearables & Smartphone Apps Increase Physical Activity Among People With Cardiovascular Disease
• Remote Monitoring Did Not Reduce Readmissions Or Increase Time At Home After Serious Infection
• Hone Health Launches Cardiovascular Care Program Focused On Earlier Heart Disease Risk Assessment
• Tennessee to Verify Immigration Status of All Public Benefit Recipients Starting July 1

To sign-up for monthly Chronic Disease Management alerts, you must be signed in to your account.